In all of the PDA cell lines we tested, the growth inhibitory effect of CDDO-Me was attributed to the induction of apoptosis as determined by the binding of annexin V-FITC and cleavage of PARP-1 and procaspases-3, -8, and -9. The gene discussed is ANXA5; the disease is Patent ductus arteriosus.